Bruton’s Tyrosine Kinase Revealed as a Negative Regulator of Wnt–β-Catenin Signaling
- 26 May 2009
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 2 (72), ra25
- https://doi.org/10.1126/scisignal.2000230
Abstract
Combining an siRNA screen with a small-molecule screen reveals BTK as a nuclear inhibitor of the Wnt–β-catenin pathway.Keywords
This publication has 44 references indexed in Scilit:
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyNature Biotechnology, 2008
- STRING 8--a global view on proteins and their functional interactions in 630 organismsNucleic Acids Research, 2008
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activityNature, 2008
- STITCH: interaction networks of chemicals and proteinsNucleic Acids Research, 2007
- ChemBank: a small-molecule screening and cheminformatics resource databaseNucleic Acids Research, 2007
- Small-molecule synergist of the Wnt/β-catenin signaling pathwayProceedings of the National Academy of Sciences of the United States of America, 2007
- Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 DisruptionsMolecular and Cellular Biology, 2006
- THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASEAnnual Review of Cell and Developmental Biology, 2004
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003